Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 227Lymphoma 225Lymphoma, Non-Hodgkin 197Leukemia, Lymphocytic, Chronic, B-Cell 176Lymphoma, Large B-Cell, Diffuse 171Lymphoma, Follicular 167Lymphoma, B-Cell 109Lymphoma, Mantle-Cell 103Hodgkin Disease 99Leukemia, Myeloid, Acute 96Recurrence 94Multiple Myeloma 89Burkitt Lymphoma 86Leukemia 76Neoplasms 66Hematologic Neoplasms 58Lymphoma, B-Cell, Marginal Zone 57Myelodysplastic Syndromes 52Waldenstrom Macroglobulinemia 43Lymphoma, T-Cell 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, T-Cell, Peripheral 36Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Leukemia, B-Cell 27Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 24Lymphoproliferative Disorders 20

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ventricular Dysfunction, Left × Lymphoid × 90 days × Clear all
NCT07572175 2026-05-07

SPARTACUS

Icahn School of Medicine at Mount Sinai

Phase 2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡